Drugs Disributed by Teva Israel LTD, Israel
Calcineurin Inhibitors, Immunosuppressant. Tacrolimus 0.5, 1, 3, 5 mg. PR Caps.50 X0.5/1/3/5 mg
For kidney transpl.: Once dly in the morn., on empty stomach, 0.20 - 0.30 mg/kg within 24 h from surg. complet. Dose to be adjust. as per clinic. assess. For liver transpl.: Once dly in the morn., on empty stomach, 0.10 - 0.20 mg/kg within 12-18 h from surg. complet. Dose to be adjust. as per clinic. assess.
Prophylaxis of transpl. reject. in adult kidney or liver allograft recipts.. Tmt. of allograft reject. resist. to tmt. with other immunosuppress. in adult kidney or liver allograft recip. ptts.
C/I: Hypersens. incl. other macrolides.
TCA. Amitriptyline 10 mg. FC tab.X 28
Major depress. disord. Tmt. should be init. at low level and incr. grad., noting carefully clinic. resp. and evidence of intolerab. Adlts.: init. 25 mg 2 times/d (50 mg/d). If necessary, can be incr. by 25 mg every other d. up to 150 mg/d div.in 2 doses.
Nocturnal enuresis ped. pop.
• childr. aged 6 to 10: 10 mg – 20 mg/d. A suitable dosage form should be used for this age group.
• childr. aged 11 and above: 25 mg – 50 mg/d. Dose should be incr. grad. To be admin. 1-1½ hours before bedtime.
Relief of symptoms of depress. Endogenous depress. is more likely to be
alleviated than other depress. states.
Enuresis nocturna
C/I: Recent MI. Any degree of heart block or disord. of cardiac rhythm and coron. artery insuff./ Concom. tmt. with MAOIs. Tmt. with amitriptyline may start 14 days after discont. of irrevers. non- select. MAOIs and min. one d. after discont. of the revers. moclobemide. Tmt. with MAOIs may be introd. 14 days after discont. of amitriptyline/Sev. liver dis./Childr. under 12 years of age.
Potassium Channel Blocker. Fampridine 10 mg. PR Tabs 28/56 X 10 mg
One 10 mg tab, twice daily, taken 12 hours apart .
Improvem. of walking in adlt. pts. with MS with walking disab. (EDSS 4-7)
C/I: Hypersens. Conc. tmt. with other med. prod. contain. fampridine (4-aminopyridine). Pts. with hist.or current seizures. Pts. with mild, mod. or sev. renal impairm. (creat. clear. <80 ml/min).
Concom. use with inhibit. of Organic Cation
Transporter 2 (OCT2) for ex., cimetidine.
Opioid Anaesthetic. Fentanyl (as Citrate) 100, 200, 400, 600, 800 mcg. BUCCAL TABS.: 28. Dosage must be
ajust. individ. for each pt.
Tmt. of BTP in adults with cancer who are
already receiving maint. opioid ther. for
chron.cancer pain. BTP is a transitory
exacerb.ation of pain that occurs on a
background of otherwise control.persist.
ent pain. Pts. receiving maint. opioid ther.
are those who are taking at least 60 mg of
oral morphine dally, at least 25 mcg. of
transder. fentanyl per hour, at least 30 mg
of oxycodone daily, at least 8 mg of oral
hydromorphone daily or an equianalgesic
dose of another opioid for a week or
longer.
C/I: Hypersens. Pts. without maint. opioid
ther. as there is an incr.risk of respir.
depres. Sev. respir. depres. or severe
obstruct. lung condit. Tmt. of acute pain
other than breakthrough pain. ADD. Pts. being treated with drugs contain. sodium oxybate
Hematinic. Iron (as Ferric carboxymaltose) 50 mg/ml. Dispers. for inf. VIAL: 1/2/5 X 2 ml/10 ml; 1 X 20 ml
Admin. 1000 mg once/w.
Tmt. of iron defic. when oral iron preparat. are ineffective or cannot be used. The diagnosis must be based on lab. tests
C/I: Hypersens. incl. to other inject. iron preparations. Anemia not caused by iron defic. Iron excess or hereditary disorder in iron utilization.
Lansoprazole 30 mg. Gatro res. caps. 28 X 30 mg
1-2 caps/day for adults and adolesc. aged 12-17
Tmt. of duodenal and gastric ulcer/Tmt. of reflux oesophagitis/
Prophyl. of reflux oesophagitis/ Eradic. of H. pylori concurr. given with antibiotic ther. for tmt. of H.pylori-assoc. ulcers/
Tmt. of NSAID-assoc. benign gastric and duodenal ulcers in pts. req.continued NSAID tmt./
Prophyl. of NSAID-assoc. gastric ulcers and duodenal ulcers in pts. at risk req. continued ther/ Symptom. gastroesophageal reflux dis./
Zollinger-Ellison syndr.
C/I: Hypersens. Concom. use with rilpivirine
